Q2 EPS Estimates for CytomX Therapeutics Reduced by Wedbush
CytomX Therapeutics, Inc. (NASDAQ:CTMX – Free Report) – Research analysts at Wedbush decreased their Q2 2025 earnings per share estimates for shares of CytomX Therapeutics in a research report issued on Monday, May 12th. Wedbush analyst R. Driscoll now expects that the biotechnology company will earn ($0.14) per share for the quarter, down from their […]
CytomX Therapeutics, Inc. (NASDAQ:CTMX – Free Report) – Research analysts at Wedbush decreased their Q2 2025 earnings per share estimates for shares of CytomX Therapeutics in a research report issued on Monday, May 12th. Wedbush analyst R. Driscoll now expects that the biotechnology company will earn ($0.14) per share for the quarter, down from their […]
